Annual Report on Friday might spark something, although it'll already be quite old (eg. not accounting for the $12.5m deal and F1). Doubt it's what potential shareholders are waiting for but who knows.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025